pillbase.ru

Quofenix

Active substance: delafloxacin meglumine

delafloxacin meglumine

Centralised EU authorisationActive

Marketing holder: A. Menarini Industrie Farmaceutiche Riunite s.r.l.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • Baxdela
    TABLET · DELAFLOXACIN MEGLUMINE 450 mg/1
    70842-101
    Melinta Therapeutics, LLC
  • Baxdela
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DELAFLOXACIN MEGLUMINE 300 mg/10.5mL
    70842-102
    Melinta Therapeutics, LLC
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-a8b7-76ed-a932-ebb8c916eb87,01a12094-ddcd-79d3-9ba3-408c1abaa9b4;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004860
Registration status
Active
ATC code
J01MA23
Sources
  • product · EMA · EMEA/H/C/004860 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004860 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004860 · Verified 2026-10-09